They found that, while the expression of a four-gene TLS signature was not associated with tumor cell PD-L1 expression or OS, a high TLS score in pre-treatment tumor tissues was associated with better outcomes in patients receiving immunotherapy [38]. Here, CD274 is linked to neoplasm.